Evidence of antidepressant clinical benefit inadequate

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1497, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidepressant therapy duration inadequate in US paediatrics

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 396, 2003-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Neurobiological and Clinical Effects of the Antidepressant Tianeptine

By Kasper Siegfried

CNS Drugs, Vol. 22, Iss. 1, 2008-01 ,pp. : 15-26

Adis International

Access to resources Recommend Favorite

The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profile

By Testa Luca Bhindi Ravinai Agostoni Pierfrancesco Abbate Antonio Zoccai Guiseppe GL Biondi van Gaal William J

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 397-406

Informa Healthcare

Access to resources Recommend Favorite

P450 typing for antidepressant response: evidence lacking

Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Evidence for cardiovascular benefit of homocysteine reduction

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite